Estudo randomizado | Nivolumabe adjuvante com ipilimumabe vs. nivolumabe isolado em pacientes com melanoma estágio IIIB-D ou IV ressecado. 3 Out, 2022 | 12:45h Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) – Journal of Clinical Oncology